Brief: 4D Molecular Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock
07/02/2024 04:28
Feb 6 (Reuters) - 4D Molecular Therapeutics Inc
FDMT.O :
* 4D MOLECULAR THERAPEUTICS ANNOUNCES PRICING OF UPSIZED
PUBLIC
OFFERING OF COMMON STOCK
* 4D MOLECULAR THERAPEUTICS - UPSIZED UNDERWRITTEN PUBLIC
OFFERING OF 6.6 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC
OFFERING PRICE OF $29.50 PER SHARE
Source text for Eikon: ID:nGNX27BZJf
Further company coverage: FDMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings